1.. Introduction {#S5}
================

The basal forebrain is the main source of acetylcholine (ACh) for hippocampal and neocortical structures. The basal forebrain cholinergic system (BFCS) comprises the medial septum nuclei (Ch1), Broca\'s diagonal (Ch2) and horizontal nuclei (Ch3) as well as the Nucleus basalis of Meynert (Ch4) and the Nucleus subputaminalis of Ayala ([@R41]; [@R54]). Its main neurotransmitter acetylcholine is well known to play a role in cognition which has been shown in several neurophysiological experiments and lesion studies of the BFCS ([@R44]; [@R24]; [@R10]).

In patients with Alzheimer\'s Dementia (AD), the number of cholinergic neurons in the human brain is diminished ([@R62]; [@R30]). Furthermore, MRI studies have shown that cholinergic atrophy parallels cognitive decline as the disease process is progressing ([@R18]). Current treatment strategies of Alzheimer\'s dementia aim at compensation for the cholinergic deficit by administration of ACh-esterase inhibitors (Birks 2006; [@R64]). These drugs increase neurotransmitter persistence in the synaptic cleft by pharmacological inhibition of its degradation, ameliorating cognitive symptoms ([@R1]).

Atrophy of cholinergic cells in the basal forebrain is also seen in healthy elderly subjects without clinical evidence of dementia ([@R19], [@R18]; [@R58]). Post mortem studies reported a decrease of histological markers of ACh-synthesis and cholinergic synapses during normal ageing which is accelerated in AD patients ([@R56]; [@R46]). However, it is still controversial whether cholinergic deficits are also associated with age-associated cognitive decline in subjects without evidence of dementia development. [@R65] recently reported an association of BFCS volume with cognitive performance in a small group of healthy elderly subjects without evidence of dementia. On the other hand, ACh-esterase-inhibitors have not been proven effective in elderly patients with memory complaints without dementia (mild cognitive impairment) and cholinergic cell loss seems to occur at advanced stages of AD ([@R49]; [@R17]). Furthermore, histological studies suggested that 30% of cholinergic neurons in the basal forebrain need to be lost until relevant cognitive deficits manifest (Mini-Mental State Examination/MMSE \< 24) which is questioning an association of cognition and basal forebrain volume in healthy ageing ([@R52]).

Associations of BFCS subregion volumes and cognitive domains (episodic memory, executive functions) were reported for patients with mild cognitive impairment (MCI). This association was not observed in the healthy control group ([@R20], [@R21]). Since these studies were designed to investigate differences between healthy elderly and patients with mild cognitive impairment, one needs to take into account that the control group was strictly defined as a highly functional ("hypernormal") control group without the slightest suspicion for cognitive impairment. Thus, [@R21] used a control group from the Alzheimer\'s Disease Neuroimaging Initiative (ADNI-2) comprising individuals without any memory complaints, normal memory function according to the Wechsler Memory Scale-R and a Clinical Dementia Rating Scale (CDR) score of 0. In addition, subjects with significant systemic illness or unstable medical condition were not included in the control group. Since multimorbidity has been shown to be associated with age and cognitive impairment, exclusion of participants due to non-neurocognitive medical conditions affects the prevalence of age-associated cognitive decline in the sample ([@R3]; [@R61]).

The aim of the present study is the analysis of BFCS volume associations with cognitive performance in a natural rather than a "hypernormal" cohort of elderly pre-surgical patients (≥ 65 years) without obvious symptoms of clinical dementia (MMSE score median 29 points, range 24--30, [@R16]).

2.. Methods {#S6}
===========

2.1.. Participants {#S7}
------------------

Participants were recruited as part of the BioCog project (Biomarker Development for Postoperative Cognitive Impairment in the Elderly study, [www.biocog.eu](http://www.biocog.eu/)), which is a prospective multicentre cohort study with the aim to develop a biomarker-based algorithm for risk prediction of post-operative cognitive disorders. Only patients ≥ 65 years of age presenting for an elective major surgery were recruited (for further inclusion and exclusion criteria see [Table 1](#T1){ref-type="table"}).

All patients gave written informed consent to participate in the study. The study protocol was approved by the local ethics committees and conducted in accordance with the declaration of Helsinki. The study was registered at [clinicaltrials.gov](clinicaltrials.gov) (NCT02832193).

In line with the study protocol, the first 400 out of 1033 participants recruited at two study centres in Berlin, Germany (N = 291) and Utrecht, Netherlands (N = 109) were selected for this interim analysis. In total, 2733 patients were screened for inclusion in the interim sample in both study centres. 297 out of 400 patients underwent anatomical neuroimaging. Two patients were excluded due to brain pathology interfering with the segmentation procedure. Thirteen datasets were incomplete with regard to demographic data or patients did not perform cognitive testing at all. Finally, data from 282 participants are included in the analysis (N = 204 from Berlin, N = 78 from Utrecht). Neuropsychological data were incomplete for several participants reducing the final sample size for test analysis.

2.2.. Neuropsychological assessments {#S8}
------------------------------------

One day before surgery, all participants underwent a comprehensive computerised neuropsychological test battery (CANTAB, Cambridge Cognition Ltd., UK), comprising the Paired Associate Learning (PAL), Verbal Recognition Memory (VRM), Spatial Span Length (SSP) and Simple Reaction Time (SRT). Additionally, pen-and-paper versions of the Trail-Making-Test (TMT, Parts A and B) and a manual dexterity test called the Grooved Pegboard Task (GPT) were conducted. Testing was performed by trained doctoral students and study nurses based on a standard operating procedure which was consented with two neuropsychologists.

PAL: The participant is shown different patterns in fixed locations on a screen in a randomised order. Subsequently, the patterns are obscured and the participant is asked to indicate the location where a particular pattern has been shown previously. In case of an error, the participant is asked to repeat the task for a maximum of ten trials. The task is then repeated on another stage with increased diffculty level. The first trial memory score is calculated as the number of patterns correctly allocated at first attempt for all completed stages. The PAL memory score assesses explicit visuospatial memory and has been found to indicate dementia, especially of Alzheimer\'s type ([@R36]).

VRM: The participant is shown a list of twelve words and asked to recall freely as many items as possible. Subsequently, the participant is shown a second list including the previously presented words as well as distractors and is asked to choose the items he or she recognises. The recognition procedure is repeated after twenty minutes. The number of items recognised after delay is analysed, since recognition memory has been shown to be associated with medial septal volume in the BFCS in younger participants ([@R6]). Furthermore, two studies suggest associations of BFCS volume with delayed recall in memory tasks ([@R20], [@R21]).

SSP: The participant is shown colour changing boxes on a screen. He or she is then asked to indicate the correct sequence by which the boxes have changed colours. The parameter of interest analysed is the longest sequence of boxes recalled (span length), which is thought to represent visual working memory ([@R42]).

SRT: The participant is shown a square on a computer screen. He or she is asked to respond to this stimulus by selecting a button as fast as possible. Mean response latency (reaction time) is the parameter of interest. Reaction time is considered to be a marker of fluid intelligence and age-associated decline in cognitive ability ([@R15]).

TMT: The participant is asked to connect dots marked with ascending numbers in Part A or alternating numbers and letters (e.g. 1-A-2-B-3...) in Part B. When a mistake is made, the participant is asked to correct it. Time for completion of both parts is the parameter of interest. Values above commonly used cut-off; thresholds (180s for TMT-A, 300s for TMT-B) were excluded during a plausibility check before data analysis. Part A is considered to be a measure of visual search and motor speed, whereas part B measures executive functions including cognitive alternation, working memory and attention ([@R5]; [@R12]).

GPT: The participant is asked to insert 25 pegs with a key alongside into wholes in a board. The key slots are rotated randomly, demanding visual-motor coordination skills and manual dexterity ([@R43]). Test parameter of interest is the time for completion with the dominant hand. Data from participants who exceeded a limit of 300 s for this task were excluded during the plausibility check.

Global cognitive ability 'g': The global cognitive component is derived from performance on the neurocognitive battery (above) using Principal Component Analysis (PCA) in line with previous literature ([@R57], [@R53]). The first unrotated factor was extracted from data of 303 participants enrolled at both study centres in Berlin and Utrecht with complete neurocognitive assessment. The first factor had an eigenvalue of 2.3 and explained 38.33% of the variance in test performance and is considered the global cognitive ability. In our study the factor is derived from TMT-B (factor loading 0.76), PAL (factor loading: 0.71), GPT (factor loading: 0.68), SSP (factor loading: 0.55), SRT (factor loading: 0.49) and VRM (factor loading: 0.46). Due skewed distributions, time for completion of TMT-B and GPT as well as SRT mean latency were reversed and underwent logarithmic transformation prior to PCA. The test outcomes used for extraction of \'g\' are those stated above except for the VRM: The number of words correctly remembered in the free recall has been used for calculation of g, but based on existing literature, the delayed recognition task seemed more relevant for analysis of BFCS volume associations with VRM performance ([@R6]; [@R20], [@R21]).

2.3.. MR image acquisition {#S9}
--------------------------

MR imaging was conducted on the same day the neurocognitive assessments took place. In Berlin, data were collected at the Berlin Center for Advanced Neuroimaging using a 3 T Magnetom Trio MR scanner (Siemens) with a 32-channel head coil. T1-weighted 3D structural brain scans were acquired using a MPRAGE sequence (magnetisation prepared rapid gradient echo in 192 sagittal slices, FOV: 256·256 mm^2^, voxel size: 1·1 mm^2^ at 1 mm slice thickness, TR: 2500 ms, TE: 4.77 ms, 7° flip angle). In Utrecht, data were collected with an Achieva 3 T MRI scanner (Phillips) equipped with an 8-channel head coil. For technical reasons, the scanner at this study site had to be exchanged with an identical machine equipped with a 32-channel head coil during the study. A similar T1w sequence was recorded here (192 sagittal slices, FOV: 256·232 mm^2^, voxel size 1·1 mm^3^; at 1 mm slice thickness, TR: 7.9 ms, TE: 4.5 ms, 8° flip angle).

A board-certified neuroradiologist screened all MR images for incidental findings with clinical relevance.

2.4.. MRI processing {#S10}
--------------------

### 2.4.1.. Segmentation of brain volume and brain parenchyma fraction {#S11}

T1-weighted MR images were partitioned into grey and white matter as well as cerebrospinal fluid using the standard SPM12 segmentation routine ([http://www.fil.ion.ucl.ac.uk/spm/software/](http://www.fil.ion.ucl.ac.uk/spm/software/spm12/) [spm12/](http://www.fil.ion.ucl.ac.uk/spm/software/spm12/)) in a MATLAB environment (The Mathworks, Inc., Natick, MA). Partition volume was defined as the sum of all voxels with at least 50% probability to correspond to the respective partition. Total brain volume is calculated as the sum of grey and white matter. Intracranial volume (ICV) is defined as the sum of brain volume and cerebrospinal fluid volume. Brain parenchyma fraction (BPF) is defined as the ratio of brain volume and intracranial volume which is a global marker for age related neurodegeneration. BPF decreases during ageing and has been associated with disease related cognitive impairment in Multiple Sclerosis ([@R4]; [@R25]; [@R39]; [@R55]). ICV is thought to be driven by brain growth during childhood and does not undergo shrinkage in ageing ([@R13]; [@R47]). We thus consider ICV a biomarker for archaeological maximum brain size and the BPF a marker of preserved brain volume and the degree of age related atrophy ([@R53]).

### 2.4.2.. Segmentation of the BFCS {#S12}

We have previously described the segmentation method we used for the volumetry of the BFCS ([@R35]). [@R7] described a similar method and they were able to show that the results are comparable to manual segmentation techniques.

Segmentation of the BFCS was performed using a probabilistic map of the basal forebrain presented by [@R66] which has been used in several previous imaging studies ([@R20]; [@R6], [@R8], [@R7]; [@R37]; [@R32]; [@R11]). Zaborszky and colleagues used histological slices and corresponding MR images of ten post-mortem body-donor brains (five female, age 37--75 years) without known neurological or psychiatric disease to define four cholinergic subregions in the basal forebrain. Brain sections were stained for cell bodies using a modified silver method of Gallyas. A comprehensive description of the BFCS delineation is found in the original publication ([@R66]). The probabilistic map uses a modified version of the Mesulam nomenclature. Furthermore, apart from dense cell aggregates, also scattered magnocellular neurons in adjacent structures (e.g. the basal ganglia) were included. Studies identified these neurons as cholinergic, suggesting that these are displaced cells of the Nucleus basalis Meynert ([@R51]; [@R40]). It is a point of discussion whether researchers should refer to these scattered neurons as a part of the Ch1-Ch4 system ([@R40]; [@R23]).

A voxel in this map was assigned to one of the subregions which it represented in at least four out of ten brains. The final map was referenced to the anatomical MNI (Montreal Neurological Institute) space ([@R26]).

SPM12 was used to segment MR images as well as the anatomical MNI reference brain. The DARTEL (Diffeomorphic Anatomical Registration using Exponentiated Lie algebra) toolbox was then used to create DARTEL flow fields describing deformations from the MNI reference brain to a participant\'s individual brain ([@R2]). These deformations were applied to the probabilistic map of the basal forebrain resulting in individual labelling of cholinergic subregions in a participant\'s brain scan. Volumes of cholinergic subregions in the basal forebrain were determined by counting all voxels labelled as corresponding to this regions. [Fig. 1](#F1){ref-type="fig"} shows the segmented regions in MR images of one subject.

2.5.. Statistical analysis {#S13}
--------------------------

### 2.5.1.. Analysis pipeline {#S14}

We first analysed the association of BFCS volume with the global cognitive component 'g' (primary parameter of interest). We report unadjusted and adjusted associations (for age, sex and education) in generalised linear models. To assess confounding effects of global volumes, the goodness of fit of a model including BFCS volume was compared with models including brain volume and BPF. We further analysed the associations of BFCS volume with 'g' after addition of these confounder variables into the model. We repeated the analysis correcting for scanner and centre effects. Since adjustment for these did not change the results, nor significant effects were found, the variables were dropped for post-hoc analysis of test performance analysis.

In addition, subsequent descriptive analyses were conducted to assess associations of BFCS volume and performance on each of the individual tests of the neurocognitive battery (secondary, post-hoc parameters of interest). If test performance was significantly associated with BFCS volume without adjustment, it was considered for further analysis of adjusted effects. To further assess if associations of BFCS volume with test performance are specific for a cognitive domain, we adjusted the linear model for 'g'.

In a final step, cognitive performance was analysed for quantile-dependent effects of BFCS on 'g' and performance on individual cognitive tests. This allows assessment of associations of BFCS volume with cognitive functions which are specific for low- and high-performers.

All statistical analyses were run in R3.4.1 (<https://www.R-project.org/>, [@R48]). The level of significance was set at p \< 0.05. No corrections for multiple comparisons were made.

### 2.5.2.. Descriptive analysis {#S15}

We report test performance including median performance, interquartile range and minimum-maximum range. Demographic and neuropsychological data have been compared between centres. Neuroimaging data have also been compared between MR scanners. We used the ANOVA F-test for continuous normal, the Kruskal-Wallis-test for continuous non-normal distributions and the χ^2^-test for nominal data. Correlations among independent variables are reported as Pearson\'s correlation coeffcient R.

### 2.5.3.. Generalised linear model {#S16}

We analysed the associations of BFCS volume and its subregions (in mm^3^ and per one standard deviation/SD) with cognitive performance. If a significant association of BFCS volume with subtest performance was found, we adjusted the generalised linear model (GLM) for education (classified according to ISCED/International standard classification of education in three categories), age and sex. For 'g', TMT, SRT latency, PAL memory score and GPT a Gaussian distribution was assumed, for SSP and VRM a quasi-Poisson distribution was selected. TMT, SRT and GPT scores were log-transformed before analysis. For Gaussian-distributed data, R^2^ is reported and for quasi-Poisson distributed tests, D^2^ is reported ([@R22]): D^2^ =(Null deviance -- Residual Deviance)/Null Deviance and partial D^2^= (Residual Deviance~Reduced\ Model~ -- Residual Deviance~Full\ Model~)/Residual Deviance~Reduced\ Model~.

### 2.5.4.. Quantile regression analysis {#S17}

In a second approach, cognitive performance was analysed using quantile regression ([@R34]). The rationale for quantile regression is robustness against heteroscedasticity and outliers in neuropsychological data. Rather than analysing the conditional mean as it is done with ordinary least squares (OLS) regression in GLM, quantile regression calculates conditional quantiles. E.g. quantile regression at the 0.5 quantile yields the median of a distribution of the dependent variable for a given value of the independent variable, whereas OLS regression returns the corresponding mean. Furthermore, the analysis of quantiles other than the 0.5th allows assessment of effects at the upper or lower boundaries of a distribution. This approach has appealing properties, when relevant covariates exit, but cannot be included in the regression model ([@R9]). On the other hand, quantile regression allows analysis of associations in high- and low-performing strata of the study sample.

Regression coefficients for different quantiles can be compared and tested for a statistically significant difference (referred to as heterogeneity of slopes). Heterogeneity of slopes suggests that volume affects the shape of a distribution rather than a central shift.

No transformations were applied to these variables prior to quantile regression analysis, but since count data are not eligible for quantile regression, span length was jittered to approximate a continuous distribution ([@R38]).

The Barrodale and Roberts algorithm implemented in the quantreg package was used for computation of quantile regression coefficients ([https://CRAN.R-project.org/package=quantreg](https://cran.r-project.org/package=quantreg), [@R33]). We report quantile regression results in scatter plots with quantile regression lines and quantile-coefficent plots (Q-C plots) for nine even spaced quantiles (0.1--0.9) with 95% confidence intervals (CI). Heterogeneity of slopes between the 0.5th and the lowest performing quantile (0.1th or 0.9th, respectively) was analysed using ANOVA. CI and p-values are based on the assumption of non-identical standard errors (called "nid" in the quantreg code).

3.. Results {#S18}
===========

[Fig 2](#F2){ref-type="fig"} is the Consort Diagram for the sample. Demographic information on the study participants is provided in [Table 2](#T2){ref-type="table"}. Neuropsychological test performance including the respective number of analysed datasets is reported in [Table 3](#T3){ref-type="table"}. Only TMT-B performance (median \[IQR\]: Berlin 101.98 s \[86.25--136.5 s\], Utrecht 104.1 s \[75--118.8 s\], χ^2^ = 6.35, p = 0.0118) and educational status (ISCED1--2 and ≥5: Berlin 21.1% and 34.3%, Utrecht: 28.2% and 44.9%, χ^2^ = 6.64, p = 0.0361) differ significantly between centres. Significant between-centre differences are found for BFCS volume (F~1,279~ = 8.65, p = 0.0036, Δ = 93 mm^3^), total brain volume (F~1,279~ =5.37, p = 0.0212, Δ= 43 cm^3^) and BPF (F~1,279~ = 6.69, p = 0.0102, Δ =0.014, [Table 4](#T4){ref-type="table"}). Mean volumes are higher in the Utrecht sample. Between-scanner effects for the study centre in Utrecht are not significant.

BFCS volume correlates with age (R = −0.26, p \< 0.0001), total brain volume (R=0.83, p \< 0.0001) and BPF (R = 0.25, p \< 0.0001). BFCS volume (F~1,280~ = 75.69, p \< 0.0001), total brain volume (F~1,280~ = 77.06, p \< 0.0001) and BPF (F~1,280~ =11.02, p = 0.0010) differ by sex. BFCS and brain volume are larger in men, while BPF is higher in women. Differences by education are found for BFCS volume (F~2,279~ =3.27, p = 0.0397), total brain volume (F~2,279~ =7.95, p = 0.0004), but not for BPF (F~2,279~ \< 0.01, p = 0.85). BFCS and brain volumes are larger in more educated subjects.

3.1.. Associations of BFCS volume with global cognitive ability {#S19}
---------------------------------------------------------------

Our primary hypothesis is an association of BFCS volume with global cognitive ability: BFCS volume is significantly associated with 'g' (R^2^ = 0.061, p = 0.0001, see [Fig 3](#F3){ref-type="fig"}). This association is largely independent of age, education and sex and remains significant after adjustment for these variables (R^2^ = 0.287, partial R^2^ = 0.041, B = 0.204 ± 0.064 per SD, p = 0.0017, see [Table 5](#T5){ref-type="table"}).

Association of BFCS subregions (CH1/2, CH3, CH4, CH4p) with global cognition are also assessed. After correction for age, sex and education, all subregions are significantly associated with 'g', and the association of BFCS with general cognition was slightly inferior to the association of 'g' and the most posterior subregion CH4p. According to R^2^, CH4p (R^2^ =0.290, partial R^2^ =0.045, p = 0.0009) is slightly more relevant for 'g' than more rostral regions CH1/2 (R^2^ =0.281, partial R^2^ =0.032, p = 0.0057), CH3 (R^2^ =0.271, partial R^2^ =0.019, p = 0.0352) and CH4 (R^2^ =0.276, partial R^2^ =0.026, p = 0.0127).

Associations of confounding global anatomical volumes (brain volume, BPF) and global cognitive abilities are tested in general linear models adjusting for age, sex and education. A considerable improvement is achieved by using a model which includes total brain volume (R^2^ =0.311, partial R^2^ =0.073, B=0.280 ± 0.065 per SD, p \< 0.0001). The association of global cognitive ability and BPF is significant, but was inferior to the model including brain volume (R^2^ =0.300, partial R^2^ =0.058, B=0.235 ± 0.062 per SD, p = 0.0002).

BFCS volume and each one of the potentially confounding volume measures are then added concurrently into two further general linear models of 'g'. When total brain volume and BFCS are included in the same model alongside with age, sex and educational status, only the association of total brain volume with global cognitive ability remains significant (partial R^2^ =0.033, B=0.274 ± 0.096 per SD, p = 0.0047), but not for BFCS (partial R^2^ \< 0.001, B=0.008 ± 0.093 per SD, p = 0.93). A model including BFCS volume and BPF shows that BFCS and BPF are independently associated with global cognitive ability (partial R^2^~BFCS~=0.023, B~BFCS~=0.154 ± 0.065 per SD, p~BFCS~=0.0191; partial R^2^~BPF~=0.040, B~BPF~=0.198 ± 0.063 per SD, p~BPF~=0.0019).

There is no significant effect of MR scanner or study centre, nor does adjustment for these alter the results.

3.2.. Associations of BFCS volume with test performance {#S20}
-------------------------------------------------------

In the unadjusted analyses, BFCS volume is significantly and positively associated with performance in all tests, except delayed recognition in the VRM.

The strongest associations are seen for TMT-B and SRT latency (R^2^ =0.073 and 0.048, respectively). Somewhat weaker associations are also found for PAL memory score, TMT-A, GPT (see [Fig 4](#F4){ref-type="fig"}) and the SSP (D^2^ =0.030, B=0.00015 ± 0.00005, B~SD~=0.034 ± 0.012, p = 0.0034, not presented in [Fig 4](#F4){ref-type="fig"}). Using a Bonferroni-corrected level of significance p′ to account for testing associations with seven cognitive tests (p′=0.05/7 ≈0.0071), only the unadjusted associations of BFCS volume with TMT-A and -B, SRT as well as SSP remained significant. Adjusting for age, education and sex yields similar associations of BFCS volume with PAL memory score, SRT latency, TMT-B and GPT. R^2^ for these models was lower than for the model of 'g'. Associations with TMT-A performance and span length are no longer significant after adjustment for age, sex and education (see [Table 6](#T6){ref-type="table"}).

VRM is the only test without significant association with BFCS volume (D^2^ = 0.005, B~SD~=0.011 ± 0.009, p = 0.22). The result for the VRM does not change after rejection of two outlying subjects (D^2^ = 0.003, B~SD~=0.0060 ± 0.0068, p = 0.38).

After adjustment for global cognitive abilities, only TMT-B performance was significantly associated with BFCS volume (partial R^2^ = 0.018, p = 0.0378). This association was no longer significant after further adjustment for age, sex and education (partial R^2^ = 0.007, p = 0.19).

3.3.. Quantile regression analysis {#S21}
----------------------------------

[Fig 5A and B](#F5){ref-type="fig"} are a graphical summary of quantile regression results of global cognitive ability and test performance. ANOVA for heterogeneity of slopes indicates that differences between associations of BFCS volume and cognitive performance between 0.5th and 0.9th quantile exist for SRT latency and GPT, but neither for the other tests nor 'g'.

For the global component, results from the GLM are reproduced in quantile regression. The association of BFCS volume and \'g\' showed no quantile-dependent trend, with significance found for all quantiles in the unadjusted model. After adjustment, significance was restricted to quantiles close to the median (B=0.0010 ± 0.0003, B~SD~=0.220 ± 0.076, p = 0.0043).

For TMT-A and -B, PAL and SSP median regression coefficients were acceptably close to the OLS estimate. Neither ANOVA nor inspection of plots suggested systematic quantile-dependent associations, especially not after adjustment for age, sex and education. With regard to significance, differences between the analysis methods occurred. On the one hand, parametric methods can be more efficient than alternative methods when data are normally distributed, explaining the more optimistic results of the GLM for the association with PAL ([@R31]). On the other hand, GLM standard errors are sensitive to outliers and skewed distributions, yielding more favourable results of quantile regression ([@R63]).

Results for the SRT and GPT differ from GLM results. For these tests, BFCS volume association with test performance differs significantly between the 0.5th and 0.9th quantile with a stronger association for the low-performance quantiles (0.9th, see [Fig 5B](#F5){ref-type="fig"}). In the adjusted models regression coefficients for the 0.1th to the 0.7th quantile are close to zero, but significant effects are found at higher quantiles for SRT latency (0.9th quantile: B=−0.198 ± 0.042, B=−44.6 ± 9.5 per SD, p \< 0.0001) and GPT completion time (0.9th quantile: B=−0.053 ± 0.018, B=−12.0 ± 4.0 per SD, p = 0.0031).

4.. Discussion {#S22}
==============

In the current study, we analysed the associations of BFCS volume with global cognitive ability and performance on several age-sensitive cognitive tests in a sample of elderly pre-surgical patients. We found significant positive associations of BFCS volume with global cognition and tests of visual memory, manual dexterity, processing speed and executive functions. BFCS volume explains more variance in the global component than in any of the cognitive test outcomes. E.g., independent of age, sex and educational status, BFCS volume explains 4.1% of the variance in 'g', but only 3.6% or less variance in test performance. This result suggests that BFCS volume is associated with better overall cognitive function in ageing rather than affecting a specific cognitive domain. This conclusion is further supported by our finding that performance in cognitive tests was no longer independently associated with BFCS volume when analyses were adjusted for 'g', suggesting that global cognitive abilities mediate the associations with test performance. However, the association of BFCS volume with global cognitive ability is driven by a more general association of total brain volume and cognition. BPF and BFCS volume are independently associated with cognition, suggesting BFCS volume has a beneficial function for cognitive reserve in atrophy-related cognitive decline. We further found that whereas the association of BFCS volume and global cognition is stable for all levels of performance, the association with SRT and GPT performance is only found for low-performing participants.

Our study needs to be discussed in the context of results reported by [@R65] and [@R21]. The former work analysed associations of BFCS subregion volumes with global cognition and test performance in 43 healthy adults aged 60--85 years with a very high IQ. After correction for intracranial volume, age and education they reported a significant association with global cognitive ability, but not with performance in single cognitive domains. Wolf\'s results support our findings with regard to an association of BFCS volume with global cognition rather than single test performance. Furthermore, we found a similar pattern of BFCS subregion contribution to global cognition: Total BFCS volume and posterior compartments (Ch4p) seem to be more relevant than anterior sections. In our study, the association of BFCS volume with 'g' was stronger than with performance in any cognitive test. Thus it is likely that this study missed associations with test performance due to lower statistical power.

[@R21] analysed the association of BFCS volume and test performance in 132 MCI subjects and 177 "hypernormal" healthy controls enrolled in the ADNI project. After controlling for age, sex and education, no significant associations with subtest performance were found in the healthy control group. Instead, significant associations with memory and attentional control were only found in the MCI group. Although the authors did not report analyses of global cognitive ability, our positive findings on BFCS volume associations with performance in single tests from the neurocognitive battery disagree with the results by Grothe and colleagues. We think that to some extent these differences can be explained by clinical differences in the analysed groups. Whereas the respective studies analysed unusually high performing elderly individuals, cognitive performance in our cohort had greater variance and most likely includes subjects with preclinical cognitive impairment. For instance, comparison of TMT performance, which is reported in all aforementioned studies, suggests that Wolf et al. (TMT mean time: A 36.6 s, B 91.1 s) and Grothe et al. (TMT mean time: A 33.7 s, B 80.3 s) analysed subject groups with better performance compared to the BioCog cohort (TMT mean time: A 48.8 s, B 113.0 s). [@R59] presented age-stratified normative data for the TMT. The average performance in Wolf\'s and Grothe\'s samples were better than 50% and 70% of the reference group (70--74 years) in Tombaugh\'s data, whereas the BioCog cohort mean corresponds to the 30th percentile of this reference group. We further compared TMT performance in our sample to reference data stratified by prevalence and future incidence of dementia in a sample of patients aged over 70 years ([@R27]). Although TMT performance of 75% of the BioCog cohort is close to the reference value of the group without prevalent dementia or future conversion (TMT mean time: A 56.7 s, B128.8 s), the TMT completion time in the worst performing quartile of our sample is closer to the groups with incident (TMT mean time: A 87 s, B 186 s), or prevalent dementia (TMT mean time: A 112 s, B 208 s) in that study.

Both the sample analysed by Wolf as well as the control subjects from the ADNI project included in the study by Grothe underwent additional dementia screening (Clinical Dementia Rating Scale, Stamm Screening Questionnaire and International Checklist of ICD-10 and DSM-IV). Dementia screening in the BioCog study is restricted to consultation of medical records and patient interview for neuropsychiatric diseases as well as MMSE assessment. The MMSE score was designed originally as a bedside screening tool for dementia, but is not generally recommended as a diagnostic criterion for dementia ([@R16]; [@R60]). Comparisons of the MMSE score with the Clinical Dementia Rating Scale (CDR) in a memory clinic suggested that among patients with score of 26--29 points, about 40% have a CDR score of 0.5 or 1, corresponding to probable or mild dementia ([@R45]). The authors further reported CDR scores of at least 0.5 (probable dementia) for all patients with MMSE scores below 26. This study reports the limited ability of the MMSE score to exclude patients with pre-existing cognitive impairment, which might also apply to the BioCog study (MMSE cut-off at 24 points). Furthermore, the BioCog study only includes elderly pre-operative patients with an indication for surgery and the overall morbidity of the cohort is probably higher compared to the groups analysed by [@R21] and [@R65]. [@R61] reported associations of multimorbidity and mild cognitive impairment which implies that pre-clinical cognitive decline might occur more often in the clinical sample presented here. Overall, our considerations suggest that a larger proportion of patients with (mild) cognitive impairments in the BioCog group contributes to the significant associations of cognitive performance with BFCS volume compared to the group analysed by [@R21].

To further test this assumption in our data, we used quantile regression analysis to assess the association of BFCS volume with test parameters for different levels of performance. Although in this analysis statistical significance was found only for subjects with median global cognitive ability, we found no quantile-dependent association of BFCS and global cognition, suggesting that BFCS volume is associated with better cognitive performance at all stages of age-associated cognitive decline. Since the association seems to be very stable also for high-performing subjects we suggest that this might contribute to the findings by [@R65]. Further analysis of SRT and GPT, which are tests of reaction time and visual-motor control, revealed significantly different associations for the 0.5th and the lowest performing quantile. Independent associations have only been found in poorly achieving subjects. These findings suggest that their association with BFCS volume seems to be specific for individuals with low task performance. It is possible that BFCS volume limits minimum performance in these participants, rather than improving performance in average- to high-performers. This might point to a function of BFCS volume as a structural cognitive reserve which is recruited in low performing subjects, but with regard to the different results of the studies mentioned above, it shows that the association of BFCS volume with test performance indeed depends on the overall performance level of the study group. Whereas Wolf and Grothe might have missed significant associations by recruiting only high performing participants, our results might be driven by a higher fraction of subjects with relevant age-related cognitive decline.

As pointed out above, most differences between studies may arise from differences in sample composition. Even so, some additional differences between these studies need to be taken into account. The BFCS volumes we report are considerably larger than those reported by Wolf and Grothe. Furthermore, the MRI derived volumes in our study are larger than the work by [@R66] suggest. Thus, it seems unlikely that these differences are caused by varying degrees of BFCS atrophy between the studies. Instead, we need to take into account that we used a probabilistic map of the BFCS which was derived from histological sections of ten brains. The map summarises brain regions with at least 40% overlap from these brains. In contrast to this, Wolf and Grothe report to have used a BFCS map based on one single brain ([@R30]). Thus, our method overestimates absolute BFCS volume. On the other hand, the location of cholinergic cells in the basal forebrain has high inter-individual variability, limiting the generalisability of single-subject based maps for larger populations ([@R66]). The choice of the appropriate method is thus a point of discussion and the lack of a final recommendation reinforces the need for different studies using complementing approaches.

Our study has greater statistical power by including more participants than Wolf and colleagues and by refusing to correct for multiple independent tests. Especially after a significant association between 'g' and BFCS volume has been shown, it is not reasonable to assume independence of the various tests ultimately constituting the basis of global cognitive ability ([@R28], [@R29]; [@R14]).

Notably, we found no association of BFCS volume and episodic memory in VRM. Thus our results could not reproduce findings from studies on younger samples and MCI patients ([@R6]; [@R20], [@R21]). Apart from differences in sample composition, methodological differences also need to be taken into account to explain these findings. First, only one of these studies has reported a sample size comparable to the dataset presented here. Second, Butler and colleagues reported associations with source memory accuracy and discriminability rather than recognition memory. Finally, the association of BFCS volume and episodic memory seems to be specific for subjects with impairment in the memory domain. For instance, [@R21] suggested that BFCS atrophy effects on cognition are mediated by disease-related cortical dysfunction.

4.1.. Limitations {#S23}
-----------------

In our study, 'g' has been calculated from several cognitive tests using principal component analysis. Thus, analysis of global cognitive abilities and subtest performance is to some extent redundant. We cannot exclude the possibility that our 'g' is biased towards measuring cognitive subdomains, e.g. with over-representation of short term memory (PAL, SSP, VRM free recall) and under-representation of long-term memory. As a consequence, we also might overestimate the association of volumes and 'g' by including tests of cognitive domains which might have an unusual strong association with BFCS volume. This is of particular relevance, since in the unadjusted models, the association of BFCS volume with TMT-B performance was stronger than the association with 'g', which nevertheless was confounded by age, education and sex.

Segmentation of cholinergic cell groups in the basal forebrain cannot be based on visual features of the cells in MR images ([@R58]; [@R65]). Therefore, we have to assume that volumetric data of the BFCS have relatively more noise contamination than brain volume which can be segmented by voxel intensity. Thus, associations of cognition and brain volume are a priori stronger than associations of cognition and BFCS volume due to noise distribution. Finally, our results are to some extent inconclusive with respect to the relative relevance of BFCS and total brain volume for cognition.

5.. Conclusion {#S24}
==============

We were able to extend previous reports of BFCS volume association with global cognitive performance in a large sample of older adults. Our results suggest that contradictory findings of BFCS volume effects on subtest performance reflect a specific association for low-performing individuals, although these findings need further evidence.
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![Location of the BFCS in one individual. The Ch1/2 region is displayed in blue, Ch3 in red. Ch4 is shown in yellow and Ch4p corresponds to the green area. We refer to a modified version of the Mesulam-nomenclature ([@R66]). (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)](nihms-1000559-f0001){#F1}

![Consort diagram. For this cross-sectional analysis, datasets have been included which have been defined as drop-outs for longitudinal analysis due to missing primary endpoints (assessment of post-operative delirium). AE refers to adverse event.](nihms-1000559-f0002){#F2}

![Association of BFCS volume with global cognitive ability. B indicates the change in \'g\' per 1 mm^3^ and one standard deviation (B-SD) change in BFCS volume. Regression coefficients (B), p-value and R^2^ correspond to the unadjusted model.](nihms-1000559-f0003){#F3}

![Association of BFCS volume with test performance. B indicates the change in the test parameter per 1 mm^3^ and one standard deviation (B-SD) change in BFCS volume. Regression coefficients (B), p-value and R^2^ correspond to the unadjusted model.](nihms-1000559-f0004){#F4}

###### 

A: Quantile regression results of 'g' and test performance. The left column shows scatter plots with regression lines for the 0.1th, 0.5th (median) and 0.9th quantile. The columns on the right display quantile-coeffcient plots for simple (unadjusted, middle) and multiple quantile regression adjusting for age, sex and education (right). The regression coefficient for BFCS volume (white --■--) are displayed for each quantile (x-axis) with 95% CI (blue area). Solid and dashed lines mark the OLS regressions result with 95% CI. ANOVA results correspond to analysis for slope heterogeneity between median and lowest-performing quantile. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
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###### 

Inclusion and exclusion criteria of the BioCog study.

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Inclusion criteria                                               Exclusion criteria
  ---------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------
  • Age ≥65 years\                                                 • MMSE score ≤ 23 points at inclusion\
  • European descent (Caucasian)\                                  • Neuropsychiatric morbidity (including addiction), which limits the conduction of the neurocognitive testing\
  • Major elective surgery with planned operation time ≥ 60 min\   • Anacusis or hypacusis, which limits the conduction of the neurocognitive testing\
  • Ability to give informed consent                               • Centrally acting medication (e.g. antidepressants or tranquillizers)\
                                                                   • Homelessness or inability to reach patient for follow-up\
                                                                   • Participation in another prospective interventional clinical study during hospital stay\
                                                                   • Accommodation in an institution due to an offcial or judicial order\
                                                                   • Missing informed consent for saving and handing out pseudonymous data

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

Demographic description of the study sample. ISCED refers to the International standard classification of education.

                                   Median   Interquartile Range   Range
  ----------- -------------------- -------- --------------------- --------
  Age         (years)              72       68--76                65--87
  MMSE        (points)             29       28--30                24--30
                                   N        \%                    
  Sex         Female               110      39%                   
  Education   ISCED 1 and 2        65       23%                   
              ISCED 3 and 4        110      39%                   
              ISCED 5 and higher   107      38%                   

###### 

Summary of cognitive performance: Number of available datasets (N), median, full and interquartile range of performance.

  Test               Parameter of interest                              N     Median   Interquartile Range   Range
  ------------------ -------------------------------------------------- ----- -------- --------------------- --------------
  SRT                Mean correct latency (ms)                          282   290.2    252.1--348.6          200.8--801.4
  TMT-A              Time for completion (s)                            267   45       36.02--57.50          19--132
  TMT-B              Time for completion (s)                            250   100      81--113.04            25.39--298
  GPT                Time for completion (s)                            270   93       80--110               50--254.27
  SSP                Span length                                        280   5        4--5                  3--8
  PAL                Memory score                                       280   13       11--17                0--25
  VRM                Number of correctly recognised items after delay   221   22       20--23                0--24
  Global cognition   'g'                                                243   0.10     −0.50--0.74           −2.70--2.35

###### 

Summary of volumetric data: Median, full and interquartile range.

                         Median   Interquartile Range   Range
  ---------------------- -------- --------------------- ---------------
  BFCS volume (mm^3^)    2201     2035--2350            1600--2875
  Brain volume (cm^3^)   999.9    921.7--1077.4         720.6--1280.7
  BPF (fraction)         0.68     0.65--0.71            0.47--0.81

###### 

General linear model (GLM) describing BFCS volume associations with global cognitive abilities. Regression coefficients are indicated as B with standard error (SE) and the corresponding p-value. SD refers to standard deviation.

  -----------------------------------------------------------------------
  Independent variable                   B ± SE               p
  -------------------------------------- -------------------- -----------
  BFCS volume in mm^3^ (change per SD)   0.00090 ± 0.00028\   0.0017
                                         (0.204 ± 0.064)      

  Age in years                           −0.059 ± 0.011       \< 0.0001

  Male sex                               −0.347 ± 0.129       0.0075

  ISCED level 1 + 2                      − 0.449 ± 0.138      0.0013

  ISCED level 5 and higher               0.497 ± 0.122        \< 0.0001
  -----------------------------------------------------------------------

###### 

Adjusted GLM for associations of BFCS volume with test parameters. All GLM are adjusted for age, sex and education. Associations are listed as regression coefficients (B) with standard errors per one SD (standard deviation) change of BFCS volume. P-values, R^2^ and partial R^2^ for BFCS volume are indicated, except for the SSP: These values marked with an asterisk (\*) correspond to D^2^. p-values have not been corrected for multiple tests. p-values marked with a double asterisk (\*\*) are significant after Bonferroni correction for independent tests (p′ \< 0.0071).

  ----------------------------------------------------------------------------------------
  Test          B ± SE for BFCS volume per\   \(p\)          Partial R^2^\   R^2^ (D^2^)
                SD                                           (D^2^)          
  ------------- ----------------------------- -------------- --------------- -------------
  PAL           0.632 ± 0.294                 (0.0325)       0.017           0.146

  TMT-A (log)   −0.030 ± 0.024                (0.22)         0.006           0.129

  TMT-B (log)   −0.084 ± 0.028                (0.0030\*\*)   0.036           0.241

  SRT (log)     −0.039 ± 0.017                (0.0245)       0.018           0.075

  GPT (log)     −0.046 ± 0.017                (0.0085)       0.026           0.192

  SSP           0.016 ± 0.013                 (0.22)         0.005\*         0.115\*
  ----------------------------------------------------------------------------------------
